1stOncology™: Cancer Intelligence Service – Page 14466 – 1stOncology is recognized as a Top 10 Global Pharma Analytic Provider

Portola Pharmaceuticals to Present at Two Upcoming Investor Conferences

On March 6, 2018 Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) reported that Bill Lis, chief executive officer, will present at the following conferences in March (Press release, Portola Pharmaceuticals, MAR 6, 2018, View Source;p=RssLanding&cat=news&id=2336594 [SID1234524461]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

Cowen and Company’s 38th Annual Health Care Conference on Tuesday, March 13, 2018, at 8:40 a.m. Eastern Time in Boston.
Oppenheimer’s 28th Annual Healthcare Conference on Tuesday, March 20, 2018, at 10:55 a.m. Eastern Time in New York.
Both presentations will be webcast live and available for replay from Portola’s website at www.portola.com in the Investor Relations section.

Pieris Pharmaceuticals to Present at Investor Conferences in March

On March 6, 2018 Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for cancer, respiratory and other diseases, reported that Pieris will present at the following upcoming investor conferences (Press release, Pieris Pharmaceuticals, MAR 6, 2018, View Source [SID1234524460]):

The Cowen & Company 38th Annual Health Care Conference, Tuesday, March 13, 2018 at 8:40 a.m. EDT at the Marriott Copley Place in Boston. A webcast of the presentation can be accessed by visiting this link.
The Oppenheimer & Co. 28th Annual Healthcare Conference, Tuesday, March 20, 2018 at 11:30 a.m. EDT at the Westin New York Grand Central in New York City. A webcast of the presentation can be accessed by visiting this link.

Onconova Therapeutics to Present at the 30th Annual Roth Conference in March

On March 6, 2018 Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS), reported that it will present at the 30th Annual Roth conference taking place on March 11-13 at The Ritz Carlton Hotel in Dana Point, California (Press release, Onconova, MAR 6, 2018, View Source [SID1234524458]). The Company’s Chief Medical Officer, Dr. Steven Fruchtman, will present and be available for one-on-one meetings.

Presentation Details:

Date: Monday, March 12th, 2018

Time: 7:00 am PT

Location: The Ritz Carlton in Dana Point, Salon 6

The presentation will be available here on the Company’s website.

Pacira Pharmaceuticals to Present at the 2018 Barclays Global Healthcare Conference

On march 6, 2018 Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) reported that the company is scheduled to participate in an analyst-led fireside chat at the 2018 Barclays Global Healthcare Conference at 11:15 AM ET on Tuesday, March 13, 2018 in Miami (Press release, Pacira Pharmaceuticals, MAR 6, 2018, View Source;p=RssLanding&cat=news&id=2336413 [SID1234524459]).

A live audio webcast of the Pacira presentation can be accessed by visiting the "Investors & Media" section of the company’s website at investor.pacira.com. A replay of the webcast will be archived on the Pacira website for two weeks following the presentation date.

Myovant Sciences to Present at Upcoming Investor Conferences

On March 6, 2018 Myovant Sciences (NYSE: MYOV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for women’s health and endocrine diseases, reported that Lynn Seely, M.D., President and Chief Executive Officer of Myovant Sciences, will present at the following investor conferences (Press release, Myovant Sciences, MAR 6, 2018, http://investors.myovant.com/news-releases/2018/03-06-2018-220102504 [SID1234524457]):

Cowen 38th Annual Healthcare Conference on Monday March 12, 2018 at 2:50 p.m. ET
Barclays Global Healthcare Conference on Tuesday March 13, 2018 at 10:15 a.m. ET

The events will be webcast live and may be accessed via the Events page under the Investors and Media section of Myovant’s website at www.myovant.com. Please connect to the company’s website at least 15 minutes prior to the presentation to ensure adequate time for any software download that may be required to listen to the webcast. A replay will also be available at the same location for 30 days following the conference.